Back
Northrop Grumman Corp. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Buy
58
NOC
Northrop Grumman Corp.
Last Price:
$579.38
Seasonality Move:
5.92%
Sell
34
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.60
Seasonality Move:
-18.07%
Buy
58
Northrop Grumman Corp. (NOC)
is a Buy
Is Northrop Grumman Corp. a Buy, Sell or Hold?
-
The current Northrop Grumman Corp. [NOC] share price is $584.66. The Score for NOC is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
NOC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.66. The Score for INKT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NOC Stock Price Chart
What is Northrop Grumman Corp.'s stock price today?
-
The Northrop Grumman Corp. share price today is $584.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NOC is experiencing buying pressure, which is a positive indicator for future bullish movement.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.66Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
NOC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 61.26 | Buy |
| Chaikin Money Flow: | 489926 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (553.07 - 571.87) | Buy |
| Bollinger Bands (100): | (563.29 - 601.47) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 45.57 | Sell |
| Chaikin Money Flow: | -9637 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.88 - 12.26) | Buy |
| Bollinger Bands (100): | (12.18 - 15.12) | Sell |
NOC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 568.89 | Buy |
| 20-day SMA: | 561.64 | Buy |
| 50-day SMA: | 574.5 | Buy |
| 200-day SMA: | 541.94 | Buy |
| 8-day EMA: | 568.73 | Buy |
| 20-day EMA: | 565.48 | Buy |
| 50-day EMA: | 570.31 | Buy |
| 200-day EMA: | 548.93 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.95 | Sell |
| 20-day SMA: | 11.68 | Sell |
| 50-day SMA: | 12.75 | Sell |
| 200-day SMA: | 11.91 | Sell |
| 8-day EMA: | 11.81 | Sell |
| 20-day EMA: | 11.94 | Sell |
| 50-day EMA: | 12.56 | Sell |
| 200-day EMA: | 12.21 | Sell |
Northrop Grumman Corp. Earnings Growth & NOC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $2.80 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Northrop Grumman Corp. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||